Pegylated mutated clostridium botulinum toxin

Details for Australian Patent Application No. 2007224669 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Frevert, Jurgen; Specht, Volker

Agent Wrays

Pub. Number AU-B-2007224669

PCT Pub. Number WO2007/104567

Priority 06005300.6 15.03.06 EP

Filing date 15 March 2007

Wipo publication date 20 September 2007

Acceptance publication date 13 May 2010

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/104567 Priority application(s): WO2007/104567

14 January 2010 Assignment before Grant

  Biotecon Therapeutics GmbH The application has been assigned to Merz Pharma GmbH & Co. KGaA

13 May 2010 Application Accepted

  Published as AU-B-2007224669

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007224678-Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs

2007224668-Substance for the treatment of tinnitus